Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

BERLIN, Conn.—Here’s a job the computers can take without much complaint: sorting recyclables. For humans, it is a foul, laborious job that entails standing over a conveyor belt, plucking beer cans ...

Geezer Butler recently hailed the advantages of artificial intelligence, saying it helped him develop songs for his upcoming solo album. Butler was asked about his current activities following Black ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

"We have demonstrated that it is impossible to describe all aspects of physical reality using a computational theory of quantum gravity," says Dr. Faizal. "Therefore, no physically complete and ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

OpenAI CEO Sam Altman is obsessed with codifying your biology. First it was scanning your eyeballs — and now it’s scanning your thoughts. The insight is based on a new hiring decision by Altman. He’s ...

Altman taps a leading researcher for his brain-computer interface startup, suggesting a much less invasive approach than Elon Musk’s Neuralink. Altman taps a leading researcher for his brain-computer ...